| Increased levels of plasma thrombomodulin in patients with acute myocardial infarction who had thrombolytic therapy and achieved successful reperfusion. | |
| | |
MedLine Citation:
|
PMID: 11346245 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: There is a growing body of evidence from animal and in vitro studies for the existence of reperfusion injury after thrombolytic therapy for acute myocardial infarction (AMI), but the patient data are limited. HYPOTHESIS: We aimed to examine the plasma thrombomodulin (TM) levels as a marker of endothelial injury and to investigate the effect of successful reperfusion on these levels. METHODS: The study included 32 patients who had a first episode of acute myocardial infarction (AMI) and received intravenous streptokinase therapy. RESULTS: Thrombomodulin levels increased significantly at 60 min after thrombolysis compared with the levels before thrombolytic therapy (0 min) in 21 (66%) patients who had successful reperfusion (49.09 +/- 10.51 vs. 25.76 +/- 5.55 ng/ml, p < 0.001). There was no difference between the TM levels at 0 and at 60 min of thrombolysis in the remaining 11 (34%) patients who could not achieve reperfusion (27.81 +/- 6.32 vs. 28.72 +/- 7.28 ng/ml, p = 0.35). CONCLUSION: There was a significant increase in TM levels at 60 min after thrombolysis in a group of patients with AMI who achieved successful reperfusion; this increase may have been caused by the activation/injury of endothelial cells. Data also suggest that the increment in TM levels may be predictive of the potential success of thrombolytic therapy. |
| | |
Authors:
|
M Ileri; I Hisar; E Yetkin; F Koşar; S Cehreli; S Korkmaz; D Demirkan |
Related Documents
:
|
1630395 - Changes in drug treatment and case fatality of patients with acute myocardial infarctio... 9741505 - Clinical predictors of early infarct-related artery patency following thrombolytic ther... 2495745 - The thrombolytic effects of native tissue-type plasminogen activator (ak-124) on experi... 11722975 - Ham-wasserman lecture: role of the plasminogen system in fibrin-homeostasis and tissue ... 11715355 - Future perspectives and implications. 10844105 - Chronic administration of moxonidine suppresses sympathetic activation in a rat heart f... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Clinical cardiology Volume: 24 ISSN: 0160-9289 ISO Abbreviation: Clin Cardiol Publication Date: 2001 May |
Date Detail:
|
Created Date: 2001-05-10 Completed Date: 2001-09-27 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 7903272 Medline TA: Clin Cardiol Country: United States |
Other Details:
|
Languages: eng Pagination: 377-9 Citation Subset: IM |
Affiliation:
|
Türkiye Yüksek Ihtisas Hastanesi, Department of Cardiology, Ankara. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Endothelium, Vascular / pathology Female Fibrinolytic Agents / therapeutic use Humans Male Middle Aged Myocardial Infarction / blood*, drug therapy* Myocardial Reperfusion Streptokinase / therapeutic use Thrombolytic Therapy* Thrombomodulin / blood* |
| Chemical | |
Reg. No./Substance:
|
0/Fibrinolytic Agents; 0/Thrombomodulin; EC 3.4.-/Streptokinase |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Prognostic significance of bundle-branch block in acute myocardial infarction: the importance of loc...
Next Document: Adequacy of anticoagulation in patients with atrial fibrillation: effect of various parameters.